Literature DB >> 23086931

Sertoli cell-specific expression of metastasis-associated protein 2 (MTA2) is required for transcriptional regulation of the follicle-stimulating hormone receptor (FSHR) gene during spermatogenesis.

Shun Zhang1, Wei Li, Chuchao Zhu, Xiaohong Wang, Zhen Li, Jinshan Zhang, Jie Zhao, Jing Hu, Teng Li, Yuanqiang Zhang.   

Abstract

BACKGROUND: Desensitization of FSH response by down-regulation of FSHR transcription is critical for FSH action.
RESULTS: Chromatin modifier MTA2 participates in the down-regulation of FSHR transcription.
CONCLUSION: The FSH/Ar/MTA2 cascade may serve as an indispensable negative feedback mechanism to modulate FSH transduction events in Sertoli cells. SIGNIFICANCE: Our findings provide new insights into mechanisms by which FSH is deregulated in male infertile patients. The effect of follicle-stimulating hormone (FSH) on spermatogenesis is modulated at a fundamental level by controlling the number of competent receptors present at the surface of Sertoli cells (SCs). One underlying mechanism is the down-regulation of the expression levels of the FSH receptor (FSHR) gene after exposure to FSH. Here we report that metastasis-associated protein 2 (MTA2), a component of histone deacetylase and nucleosome-remodeling complexes, as a gene product induced directly by testosterone or indirectly by FSH, is exclusively expressed in SCs. Stimulation of SCs with FSH is accompanied by up-regulation of MTA2 expression and enhancement of deacetylase activity. This effect requires the integrity of functional androgen receptor. Furthermore, MTA2 is a potent corepressor of FSHR transcription, because it can recruit histone deacetylase-1 onto the FSHR promoter and participates in the down-regulation of FSHR expression upon FSH treatment. Abolishment of endogenous MTA2 by siRNA treatment disrupted the desensitization of the FSH response and thereafter impaired the FSH-dependent secretory function of SCs. From a clinical standpoint, deregulated expression of MTA2 in SCs of human pathological testes negatively correlates to the deregulated level of serum FSH. Overall, our present results provide the first evidence that the FSH/androgen receptor/MTA2 cascade may serve as an indispensable negative feedback mechanism to modulate the transduction events of SCs in response to FSH. These data also underscore an unexpected reproductive facet of MTA2, which may operate as a novel integrator linking synergistic actions of FSH and androgen signaling in SCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23086931      PMCID: PMC3504762          DOI: 10.1074/jbc.M112.383802

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Mechanisms involved in the homologous down-regulation of transcription of the follicle-stimulating hormone receptor gene in Sertoli cells.

Authors:  M D Griswold; J S Kim; W A Tribley
Journal:  Mol Cell Endocrinol       Date:  2001-02-28       Impact factor: 4.102

2.  Regulated hyperacetylation of core histones during mouse spermatogenesis: involvement of histone deacetylases.

Authors:  M Hazzouri; C Pivot-Pajot; A K Faure; Y Usson; R Pelletier; B Sèle; S Khochbin; S Rousseaux
Journal:  Eur J Cell Biol       Date:  2000-12       Impact factor: 4.492

3.  Quantitative reverse transcriptase polymerase chain reaction assay for mouse androgen receptor mRNA.

Authors:  G J Foxley; Q Dong; D J Handelsman
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

4.  Follicle-stimulating hormone (FSH) regulates the expression of FSH receptor messenger ribonucleic acid in cultured Sertoli cells and in hypophysectomized rat testis.

Authors:  S M Maguire; W A Tribley; M D Griswold
Journal:  Biol Reprod       Date:  1997-05       Impact factor: 4.285

Review 5.  Anti-müllerian hormone and sertoli cell function in paediatric male hypogonadism.

Authors:  Romina P Grinspon; Rodolfo A Rey
Journal:  Horm Res Paediatr       Date:  2010-02-09       Impact factor: 2.852

6.  Localization and in situ quantification of 5-hydroxytryptamine and its receptor in rat submaxillary gland.

Authors:  Weiquan Huang; Lan Sun; Baozhen Lü; Wei Wang; Ruolei Pu; Lei Chen; Yongjuan Xia
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

7.  In vivo effects of histone-deacetylase inhibitor trichostatin-A on murine spermatogenesis.

Authors:  Irina Fenic; Violetta Sonnack; Klaus Failing; Martin Bergmann; Klaus Steger
Journal:  J Androl       Date:  2004 Sep-Oct

8.  The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity.

Authors:  Ya-Li Yao; Wen-Ming Yang
Journal:  J Biol Chem       Date:  2003-08-13       Impact factor: 5.157

Review 9.  Androgen receptor gene and male infertility.

Authors:  E L Yong; C J Loy; K S Sim
Journal:  Hum Reprod Update       Date:  2003 Jan-Feb       Impact factor: 15.610

10.  Misregulation of histone acetylation in Sertoli cell-only syndrome and testicular cancer.

Authors:  A K Faure; C Pivot-Pajot; A Kerjean; M Hazzouri; R Pelletier; M Péoc'h; B Sèle; S Khochbin; S Rousseaux
Journal:  Mol Hum Reprod       Date:  2003-12       Impact factor: 4.025

View more
  10 in total

Review 1.  Physiological functions of MTA family of proteins.

Authors:  Nirmalya Sen; Bin Gui; Rakesh Kumar
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

2.  Unexpected requirement for a binding partner of the syntaxin family in phagocytosis by murine testicular Sertoli cells.

Authors:  Y-s Dong; W-g Hou; Y Li; D-b Liu; G-z Hao; H-f Zhang; J-c Li; J Zhao; S Zhang; G-b Liang; W Li
Journal:  Cell Death Differ       Date:  2015-10-23       Impact factor: 15.828

3.  Identification of testicular Foxq1 as a critical modulator of lactate metabolism in mouse Sertoli cells.

Authors:  Zetao Liu; Mingyou Yuan; Xiangxiang Meng; Haiwen Bie; Shaobo Yao
Journal:  Histochem Cell Biol       Date:  2021-06-05       Impact factor: 4.304

4.  Recombinant gonadotropin therapy to improve spermatogenesis in nonobstructive azoospermic patients - A proof of concept study.

Authors:  Rita Jakubcionyte Laursen; Birgit Alsbjerg; Helle Olesen Elbaek; Betina Boel Povlsen; Kirsten Brock Spanggaard Jensen; Jette Lykkegaard; Sandro C Esteves; Peter Humaidan
Journal:  Int Braz J Urol       Date:  2022 May-Jun       Impact factor: 3.050

5.  Abnormal Accumulation of Collagen Type I Due to the Loss of Discoidin Domain Receptor 2 (Ddr2) Promotes Testicular Interstitial Dysfunction.

Authors:  Chu-chao Zhu; Bin Tang; Jin Su; Hu Zhao; Xin Bu; Zhen Li; Jie Zhao; Wei-dong Gong; Zhi-qun Wu; Li-bo Yao; Wei Li; Yuan-qiang Zhang
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

6.  Upregulation and nuclear translocation of testicular ghrelin protects differentiating spermatogonia from ionizing radiation injury.

Authors:  W Li; Y Zeng; J Zhao; C-J Zhu; W-G Hou; S Zhang
Journal:  Cell Death Dis       Date:  2014-05-22       Impact factor: 8.469

7.  TGF-β signaling controls FSHR signaling-reduced ovarian granulosa cell apoptosis through the SMAD4/miR-143 axis.

Authors:  Xing Du; Lifan Zhang; Xinyu Li; Zengxiang Pan; Honglin Liu; Qifa Li
Journal:  Cell Death Dis       Date:  2016-11-24       Impact factor: 8.469

8.  Interference with lactate metabolism by mmu-miR-320-3p via negatively regulating GLUT3 signaling in mouse Sertoli cells.

Authors:  Li-Li Zhang; Jing Ma; Bo Yang; Jie Zhao; Bin-Yuan Yan; Yuan-Qiang Zhang; Wei Li
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

Review 9.  Up-To-Date Review About Minipuberty and Overview on Hypothalamic-Pituitary-Gonadal Axis Activation in Fetal and Neonatal Life.

Authors:  Lucia Lanciotti; Marta Cofini; Alberto Leonardi; Laura Penta; Susanna Esposito
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-23       Impact factor: 5.555

10.  Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer.

Authors:  Mao Li; Shun Zhang; Yuan Ma; Yang Yang; Ruifang An
Journal:  Oncol Rep       Date:  2021-04-13       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.